Actively Recruiting
Randomized, Placebo-Controlled Trial of Cranberry Phospholipids Tablets for Urination Frequency in Healthy Japanese Adults
Led by Indena S.p.A · Updated on 2026-09-30
76
Participants Needed
2
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying healthy Japanese adults who have concerns about urinary frequency to see if taking Cranberry Phospholipids can reduce how often they urinate during the day. This randomized, placebo-controlled trial compares the effects of Cranberry Phospholipids tablets versus placebo in a double-blind, parallel-group design. Participants will take two tablets daily containing either 120 mg of cranberry phospholipids or no active ingredient for eight weeks. During this time, they will complete questionnaires about overactive bladder symptoms and quality of life. The study compares changes in daytime urinary frequency and other related symptoms between the treatment and placebo groups. Throughout the study, participants will answer various questionnaires on urinary habits and overactive bladder symptoms at multiple timepoints, including baseline and after 1, 3, and 8 weeks of intervention. Researchers will also monitor safety through urinalysis, blood tests, physical measurements like height and weight, and record any adverse events. The main measure is the change in frequency of daytime urination after eight weeks of taking the tablets.
CONDITIONS
Brief Title
Effects of the Consumption of Test Product on Urination in Healthy Japanese Adults
Research Team
N
Naoko Suzuki
A
Asami Baba, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here